Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma

Analysis of a mass cytometry dataset for different human solid tumors coupled with murine reverse translational experiments suggests that targeting CD73 could enhance the efficacy of checkpoint inhibitor therapy in glioblastoma.

Read the full article here

Related Articles